BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25879339)

  • 1. Thrombocytosis as a prognostic factor in patients with renal cell carcinoma: a meta-analysis of literature.
    Men H; Liang C; Yu M
    J Cancer Res Ther; 2015; 11(1):67-72. PubMed ID: 25879339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of thrombocytosis in renal cell carcinoma patients.
    Inoue K; Kohashikawa K; Suzuki S; Shimada M; Yoshida H
    Int J Urol; 2004 Jun; 11(6):364-7. PubMed ID: 15157203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of platelet count in patients with renal cell carcinoma.
    Erdemir F; Kilciler M; Bedir S; Ozgok Y; Coban H; Erten K
    Urol Int; 2007; 79(2):111-6. PubMed ID: 17851278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De Ritis ratio (aspartate transaminase/alanine transaminase ratio) as a significant prognostic factor after surgical treatment in patients with clear-cell localized renal cell carcinoma: a propensity score-matched study.
    Lee H; Lee SE; Byun SS; Kim HH; Kwak C; Hong SK
    BJU Int; 2017 Feb; 119(2):261-267. PubMed ID: 27226065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of thrombocytosis for determining prognosis in patients with localized renal cell carcinoma.
    Göğüş C; Baltaci S; Filiz E; Elhan A; Bedük Y
    Urology; 2004 Mar; 63(3):447-50. PubMed ID: 15028435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma.
    Ito K; Asano T; Yoshii H; Satoh A; Sumitomo M; Hayakawa M
    Int J Urol; 2006 Nov; 13(11):1365-70. PubMed ID: 17083384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of preoperative platelet level in clinical and pathological outcomes after surgery for renal cortical malignancies.
    Wosnitzer M; Polland A; Hai Q; Hruby G; McKiernan J
    BJU Int; 2011 Jul; 108(1):73-9. PubMed ID: 21166746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombocytosis and hematocrit as prognostic factors in renal carcinoma.
    Seda CJ; Salas AS; Sánchez CG; Blasco JM; García IO; Sánchez JM; Ruíz CB; Navarro SM; López RA
    Arch Esp Urol; 2011 Nov; 64(9):883-90. PubMed ID: 22155876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma.
    Pflanz S; Brookman-Amissah S; Roigas J; Kendel F; Hoschke B; May M
    Scand J Urol Nephrol; 2008; 42(6):507-13. PubMed ID: 19031267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective series.
    Brookman-May S; May M; Ficarra V; Kainz MC; Kampel-Kettner K; Kohlschreiber S; Wenzl V; Schneider M; Burger M; Wieland WF; Otto W; Tilki D; Gilfrich C; Hohenfellner M; Pahernik S; Chromecki TF; Stief C; Zigeuner R;
    World J Urol; 2013 Oct; 31(5):1309-16. PubMed ID: 22903790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombocytosis is associated with a significant increase in the cancer specific death rate after radical nephrectomy.
    O'Keefe SC; Marshall FF; Issa MM; Harmon MP; Petros JA
    J Urol; 2002 Oct; 168(4 Pt 1):1378-80. PubMed ID: 12352397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased preoperative levels of plasma fibrinogen and D dimer in patients with renal cell carcinoma is associated with poor survival and adverse tumor characteristics.
    Erdem S; Amasyali AS; Aytac O; Onem K; Issever H; Sanli O
    Urol Oncol; 2014 Oct; 32(7):1031-40. PubMed ID: 25027687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative Leucocytosis, Thrombocytosis and Anemia as Potential Prognostic Factors in Non-metastatic Renal Cell Carcinoma.
    Hutterer GC; Krieger D; Mrsic E; Pohlmann K; Bezan A; Stojakovic T; Pummer K; Zigeuner R; Pichler M
    Anticancer Res; 2015 Jun; 35(6):3463-9. PubMed ID: 26026111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet count and preoperative haemoglobin do not significantly increase the performance of established predictors of renal cell carcinoma-specific mortality.
    Karakiewicz PI; Trinh QD; Lam JS; Tostain J; Pantuck AJ; Belldegrun AS; Patard JJ
    Eur Urol; 2007 Nov; 52(5):1428-36. PubMed ID: 17420085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma.
    Sengupta S; Lohse CM; Cheville JC; Leibovich BC; Thompson RH; Webster WS; Frank I; Zincke H; Blute ML; Kwon ED
    Cancer; 2006 Jan; 106(2):304-12. PubMed ID: 16353202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Serum Lactate Dehydrogenase in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Shen J; Chen Z; Zhuang Q; Fan M; Ding T; Lu H; He X
    PLoS One; 2016; 11(11):e0166482. PubMed ID: 27861542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of ABO blood group in patients with renal cell carcinoma: single-institution results from a large cohort.
    Lee C; You D; Sohn M; Jeong IG; Song C; Kwon T; Hong B; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1441-7. PubMed ID: 25687379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differing risk of cancer death among patients with pathologic T3a renal cell carcinoma: identification of risk categories according to fat infiltration and renal vein thrombosis.
    Baccos A; Brunocilla E; Schiavina R; Borghesi M; Rocca GC; Chessa F; Saraceni G; Fiorentino M; Martorana G
    Clin Genitourin Cancer; 2013 Dec; 11(4):451-7. PubMed ID: 23816525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor Prognosis Associated with High Levels of Thymidine Phosphorylase and Thrombocytosis in Patients with Renal Cell Carcinoma.
    Huang X; Wang L; Chen Y; Zheng X; Wang X
    Urol Int; 2017; 98(2):162-168. PubMed ID: 27532673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.